Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Advanced Nonhematologic Malignancies × TAK 733 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Advanced Nonhematologic Malignancies 1 Advanced Non-hematologic Malignancies 1

Interventions

sapanisertib 2 MLN 8237 2 tovorafenib 1 serabelisib 1 pevonedistat 1 TAK 733 1 Paclitaxel 1 Irinotecan 1 Cetuximab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01613261 2013-11-01

Study of TAK-733 in Combination With Alisertib in Adult Patients With Advanced Nonhematologic Malignancies

Millennium Pharmaceuticals, Inc.

Phase 1 Withdrawn

Advanced Nonhematologic Malignancies

Data powered by HemOnc (CC BY 4.0) Colophon ⚡